The FDA cracked down on two plants in India and one in Korea in separate recently released reports, citing issues ranging ...

In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile ...

Consumers are now almost as likely to say they learn about new medications from advertisements on linear or connected TV as ...

Nostrum Labs, which declared bankruptcy last year and has since ceased operations, issued a voluntary recall for all lots of ...

Illustrating its confidence in its proprietary products, the Southern California company has announced an ambitious plan to ...

Fittingly enough, for its third acquisition in as many years, Deerfield Group has picked up Triple Threat Communications. | ...

Real Chemistry has made a flurry of leadership appointments, including hiring JJ Schmuckler from VML to fill a newly created role while also making changes at 21Grams and its communications group.

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

GSK has been enjoying regulatory momentum in recent months as it works to bring its antibody-drug conjugate (ADC) Blenrep ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to ...

Under the transaction, Perrigo is handing over several popular skincare franchises, including ACO, Biodermal, Emolium and Iwostin. Perrigo acquired the latter two Eastern European brands, plus the non ...